시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 대동맥 협착증 시장 보고서(2025년)
Aortic Stenosis Global Market Report 2025
상품코드 : 1720713
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

대동맥 협착증 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예측 기간의 성장 촉진요인은 신흥시장에 있어서의 의료 액세스의 개선, 대동맥 밸브 치환 기술의 진보 등입니다. 주요 동향에는 로봇 지원 수술, 3D 화상과 가시화, 경 카테터 대동맥 밸브 치환술(TAVR)의 혁신, 진단에 있어서의 인공지능의 통합, 생분해성 스텐트의 개발 등이 있습니다.

심장 질환의 유병률 증가는 대동맥 협착증 시장의 성장을 가속할 것으로 예측됩니다. 심부전, 부정맥, 심장 판막증, 심근증 등이 있습니다. 카테터 대동맥 판막 이식술(TAVI)과 같은 치료 옵션은 적절한 심장 기능을 회복시키고 심각한 결과의 위험을 줄이는데 도움이 됩니다. 예를 들어, 2025년 1월 영국의 심혈관 연구 자선단체인 영국심장재단은 영국에서 약 760만 명(남성 약 400만 명, 여성 약 360만 명)이 심장 및 순환계 질환을 앓고 있다고 보고했습니다. 이러한 질환은 영국 전체 사망자의 약 27%를 차지하며, 매년 17만 명 이상, 즉 하루에 약 480명이 사망합니다. 이처럼 심장 질환의 부담이 증가함에 따라 대동맥 협착증 시장이 확대되고 있습니다.

대동맥 협착증 시장 주요 기업은 경 카테터 대동맥 판막 이식(TAVI) 시스템과 같은 대동맥 판막 기술의 진보에 초점을 맞추고 환자 결과를 개선하고 절차 위험을 줄이고 전반적인 치료 효과를 높이고 있습니다. 그렇지 않으면 질병의 대동맥 판막을 대체하도록 설계된 저 침습 의료기기입니다. 예를 들어, 2023년 1월, 미국에 본사를 둔 의료기기 회사인 Abbott Laboratories는 미국 식품의약국(FDA)으로부터 최신 TAVI 시스템인 Navitor에 대한 승인을 받았습니다. Navitor는 판막 주위 누출을 최소화하거나 제거하도록 설계된 NaviSeal 패브릭 커프가 특징입니다. 또한 네이티브 밸브 내의 전단지 디자인은 미래의 관상 동맥 질환 치료를 위해 관상 동맥 접근을 개선하고 대동맥 협착증을 가진 환자의 장기 관리를 향상시키는 것을 목표로 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Aortic stenosis is a condition in which the aortic valve of the heart becomes narrowed, restricting blood flow from the left ventricle to the aorta and the rest of the body. It is commonly caused by age-related valve calcification, congenital valve defects, or rheumatic fever. Aortic stenosis can result in serious complications such as heart failure, which may be managed with medication or treated through surgical interventions such as valve replacement.

The primary types of aortic stenosis include congenital aortic stenosis and acquired aortic stenosis. Congenital aortic stenosis refers to a narrowing of the aortic valve present at birth, which limits blood flow from the heart's left ventricle to the aorta. Treatment options include surgical aortic valve replacement, transcatheter aortic valve replacement, and balloon aortic valvuloplasty. These treatments are administered through different methods such as oral, parenteral, and implants. Distribution channels are divided into offline and online platforms, while end users include hospital pharmacies, retail pharmacies, and online pharmacies.

The aortic stenosis market research report is one of a series of new reports from The Business Research Company that provides aortic stenosis market statistics, including aortic stenosis industry global market size, regional shares, competitors with an aortic stenosis market share, detailed aortic stenosis market segments, market trends and opportunities, and any further data you may need to thrive in the aortic stenosis industry. This aortic stenosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aortic stenosis market size has grown rapidly in recent years. It will grow from $7.88 billion in 2024 to $8.93 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth during the historic period can be attributed to an aging population, a rising prevalence of risk factors, advancements in diagnostic technologies, increased awareness of heart diseases, and improvements in healthcare infrastructure.

The aortic stenosis market size is expected to see rapid growth in the next few years. It will grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The projected growth in the forecast period is driven by the rising adoption of minimally invasive procedures, an expanding geriatric population, increasing healthcare expenditure, improved healthcare access in emerging markets, and advancements in aortic valve replacement technologies. Key trends include robotic-assisted surgery, 3D imaging and visualization, innovations in transcatheter aortic valve replacement (TAVR), the integration of artificial intelligence in diagnostics, and the development of biodegradable stents.

The rising prevalence of heart diseases is expected to drive the growth of the aortic stenosis market. Heart diseases encompass various conditions that affect the heart's structure and function, potentially impairing its ability to pump blood effectively and leading to severe complications. Common heart diseases include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, and cardiomyopathy. Aortic stenosis, a condition characterized by the narrowing of the aortic valve, obstructs blood flow from the left ventricle to the aorta, increasing resistance and forcing the heart to work harder, which can lead to heart failure and other cardiovascular issues over time. Treatment options such as valve replacement or transcatheter aortic valve implantation (TAVI) help restore proper heart function and reduce the risk of severe outcomes. For example, in January 2025, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are living with heart and circulatory diseases, including around 4 million males and 3.6 million females. These conditions account for nearly 27% of all deaths in the UK, leading to over 170,000 fatalities annually, or approximately 480 deaths per day. This increasing burden of heart diseases is driving the expansion of the aortic stenosis market.

Leading companies in the aortic stenosis market are focusing on advancements in aortic valve technologies, such as transcatheter aortic valve implantation (TAVI) systems, to improve patient outcomes, reduce procedural risks, and enhance overall treatment effectiveness. The TAVI system is a minimally invasive medical device designed to replace a diseased aortic valve without the need for open-heart surgery. For example, in January 2023, Abbott Laboratories, a US-based medical device company, received approval from the U.S. Food and Drug Administration (FDA) for Navitor, its latest-generation TAVI system. Navitor features the NaviSeal fabric cuff, designed to minimize or eliminate paravalvular leaks. Its leaflet design within the native valve aims to improve coronary artery access for potential future treatments of coronary artery disease, offering enhanced long-term care for patients with aortic stenosis.

In August 2024, Edwards Lifesciences, a US-based heart valve technologies company, expanded its structural heart portfolio through the acquisition of JC Medical for an undisclosed amount. This acquisition strengthens Edwards Lifesciences' capabilities in transcatheter aortic valve replacement (TAVR) technologies by incorporating the J-Valve system, a specialized solution for treating severe aortic regurgitation. JC Medical, a US-based medical device company, is known for developing advanced TAVI systems to address both aortic stenosis (AS) and aortic regurgitation (AR), further enhancing treatment options for patients with complex valvular conditions.

Major players in the aortic stenosis market are AstraZeneca plc, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, Meril Life Sciences Pvt Ltd., Shockwave Medical Inc., Venus Medtech, Egnite Inc., JenaValve Technology Inc, Peijia Medical, Micro Interventional Devices Inc, CryoLife Inc., Coroneo Meril Life Sciences Pvt Ltd, Thubrikar Aortic Valve Inc., Anteris Technologies Ltd., Cardiawave.

North America was the largest region in the aortic stenosis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in aortic stenosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the aortic stenosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aortic stenosis market consists of revenues earned by entities by providing services such as surgical treatments, transcatheter aortic valve replacement, balloon valvuloplasty and medical management. The market value includes the value of related goods sold by the service provider or included within the service offering. The aortic stenosis market includes sales of medical devices, diagnostic and monitoring tools and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aortic Stenosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aortic stenosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for aortic stenosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aortic stenosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Aortic Stenosis Market Characteristics

3. Aortic Stenosis Market Trends And Strategies

4. Aortic Stenosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Aortic Stenosis Growth Analysis And Strategic Analysis Framework

6. Aortic Stenosis Market Segmentation

7. Aortic Stenosis Market Regional And Country Analysis

8. Asia-Pacific Aortic Stenosis Market

9. China Aortic Stenosis Market

10. India Aortic Stenosis Market

11. Japan Aortic Stenosis Market

12. Australia Aortic Stenosis Market

13. Indonesia Aortic Stenosis Market

14. South Korea Aortic Stenosis Market

15. Western Europe Aortic Stenosis Market

16. UK Aortic Stenosis Market

17. Germany Aortic Stenosis Market

18. France Aortic Stenosis Market

19. Italy Aortic Stenosis Market

20. Spain Aortic Stenosis Market

21. Eastern Europe Aortic Stenosis Market

22. Russia Aortic Stenosis Market

23. North America Aortic Stenosis Market

24. USA Aortic Stenosis Market

25. Canada Aortic Stenosis Market

26. South America Aortic Stenosis Market

27. Brazil Aortic Stenosis Market

28. Middle East Aortic Stenosis Market

29. Africa Aortic Stenosis Market

30. Aortic Stenosis Market Competitive Landscape And Company Profiles

31. Aortic Stenosis Market Other Major And Innovative Companies

32. Global Aortic Stenosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aortic Stenosis Market

34. Recent Developments In The Aortic Stenosis Market

35. Aortic Stenosis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기